1. Home
  2. SDSTW vs JAGX Comparison

SDSTW vs JAGX Comparison

Compare SDSTW & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stardust Power Inc. Warrant

SDSTW

Stardust Power Inc. Warrant

HOLD

Current Price

$0.10

Market Cap

3.4M

Sector

N/A

ML Signal

HOLD

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$1.16

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDSTW
JAGX
Founded
N/A
2013
Country
United States
United States
Employees
8
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
3.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SDSTW
JAGX
Price
$0.10
$1.16
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$60.00
AVG Volume (30 Days)
41.6K
380.8K
Earning Date
03-26-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$11,785,000.00
Revenue This Year
N/A
$22.41
Revenue Next Year
N/A
$30.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.45
52 Week Low
$0.10
$1.00
52 Week High
$0.12
$33.25

Technical Indicators

Market Signals
Indicator
SDSTW
JAGX
Relative Strength Index (RSI) 35.05 41.74
Support Level $0.11 $1.05
Resistance Level $0.17 $1.36
Average True Range (ATR) 0.01 0.16
MACD -0.00 0.02
Stochastic Oscillator 6.10 32.00

Price Performance

Historical Comparison
SDSTW
JAGX

About SDSTW Stardust Power Inc. Warrant

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: